Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -16.4% | 0.4% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 1.3 | 0.9 |
Pr/Book | 0.9 |
Latest | F'cast | |
---|---|---|
Revenue | -47.2% | -3.5% |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 4.50 | (3.19) | (2.96)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-21 | 13.60 | (0.18) | 0.01p | 2,050.0 | n/a | n/a | n/a | 0.0% |
30-Jun-22 | 10.46 | (2.67) | (0.82)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 33.16 | 1.09 | 0.17p | 25.0 | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 26.32 | (6.27) | (1.11)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 25.40 | 0.10 | n/a | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-25 | 31.50 | 2.40 | 0.40p | 15.9 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 36.30 | 3.80 | 0.70p | 9.1 | 0.1 | +75% | n/a | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Final Results for the 18 months ended 31 Dec 2023 | 30-Apr-2024 | 07:01 | RNS |
Major Contract Win with Spire Healthcare | 22-Apr-2024 | 07:00 | RNS |
£40m Project Funding Facility and Tra... | 01-Mar-2024 | 07:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 6.35p |
Change Today | -0.050p |
% Change | -0.78 % |
52 Week High | 7.90 |
52 Week Low | 3.50 |
Volume | 323,395 |
Shares Issued | 352.15m |
Market Cap | £22.36m |
RiskGrade | 421 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:20 | 4,356 @ 6.34p |
15:12 | 8,810 @ 6.39p |
14:53 | 1 @ 6.40p |
14:52 | 1 @ 6.40p |
14:51 | 1 @ 6.40p |
CEO | Harvey I Sinclair |
CFO | Crispin Goldsmith |
You are here: research